Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Healthtrust
Cipla
QuintilesIMS
Harvard Business School
Johnson and Johnson
Federal Trade Commission
UBS
Citi

Generated: December 12, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR KETOTIFEN FUMARATE

« Back to Dashboard

Clinical Trials for ketotifen fumarate

Trial ID Title Status Sponsor Phase Summary
NCT00426023 Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis Completed University of Genova Phase 3 This interventional study aims to evaluate the efficacy of Cyclosporine eye drop treatment in preventing relapses of Vernal Keratoconjunctivitis (VKC) and in treating the acute phases of the disease.
NCT00426023 Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis Completed University of Padova Phase 3 This interventional study aims to evaluate the efficacy of Cyclosporine eye drop treatment in preventing relapses of Vernal Keratoconjunctivitis (VKC) and in treating the acute phases of the disease.
NCT00426023 Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis Completed Campus Bio-Medico University Phase 3 This interventional study aims to evaluate the efficacy of Cyclosporine eye drop treatment in preventing relapses of Vernal Keratoconjunctivitis (VKC) and in treating the acute phases of the disease.
NCT00445120 Lactobacillus Rhamnosus GG Oral Treatment Efficacy on Vernal Keratoconjunctivitis Treatment Completed University of Genova Phase 2/Phase 3 This interventional study aims to evaluate the efficacy of oral administration of Lactobacillus Rhamnosus GG in preventing relapses of ocular inflammation in Vernal Keratoconjunctivitis (VKC) patients.
NCT00445120 Lactobacillus Rhamnosus GG Oral Treatment Efficacy on Vernal Keratoconjunctivitis Treatment Completed University of Padova Phase 2/Phase 3 This interventional study aims to evaluate the efficacy of oral administration of Lactobacillus Rhamnosus GG in preventing relapses of ocular inflammation in Vernal Keratoconjunctivitis (VKC) patients.
NCT00445120 Lactobacillus Rhamnosus GG Oral Treatment Efficacy on Vernal Keratoconjunctivitis Treatment Completed Campus Bio-Medico University Phase 2/Phase 3 This interventional study aims to evaluate the efficacy of oral administration of Lactobacillus Rhamnosus GG in preventing relapses of ocular inflammation in Vernal Keratoconjunctivitis (VKC) patients.
NCT00446056 Montelukast Post-Marketing Comparative Study With Ketotifen (0476-379) Completed Merck Sharp & Dohme Corp. Phase 4 The clinical study evaluates the safety of montelukast and compares montelukast to ketotifen, used as a control drug, in terms of improvement in morning peak expiratory flow (am pef) over first 2 weeks in patients with pediatric bronchial asthma aged 6 to < 15. The effect of body weight on the efficacy and safety of montelukast will also be evaluated in this study.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for ketotifen fumarate

Condition Name

Condition Name for ketotifen fumarate
Intervention Trials
Vernal Keratoconjunctivitis 2
Asthma 1
Nasal Obstruction 1
Allergic Conjunctivitis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for ketotifen fumarate
Intervention Trials
Conjunctivitis, Allergic 3
Dermatitis 2
Keratoconjunctivitis 2
Eczema 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for ketotifen fumarate

Trials by Country

Trials by Country for ketotifen fumarate
Location Trials
Italy 2
Singapore 1
Japan 1
Argentina 1
United States 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for ketotifen fumarate
Location Trials
Tennessee 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for ketotifen fumarate

Clinical Trial Phase

Clinical Trial Phase for ketotifen fumarate
Clinical Trial Phase Trials
Phase 4 2
Phase 3 6
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for ketotifen fumarate
Clinical Trial Phase Trials
Completed 7
Recruiting 1
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for ketotifen fumarate

Sponsor Name

Sponsor Name for ketotifen fumarate
Sponsor Trials
Campus Bio-Medico University 2
University of Padova 2
University of Genova 2
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for ketotifen fumarate
Sponsor Trials
Other 10
Industry 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Moodys
Medtronic
Federal Trade Commission
McKesson
Covington
Citi
Boehringer Ingelheim
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.